"The problem was never hormone therapy. It was one flawed study and a generation of women paid the price."
Fatigue that won't lift. Brain fog. Mood swings. Sleep that never feels restful. For many women moving through perimenopause and menopause, this is the pattern — symptoms show up, a doctor calls them "normal aging," and the conversation ends there. No testing. No real explanation. Just a suggestion to manage it and move on.
In this episode of The Resiliency Method® The Truth About Healing Podcast, Dr. Erika Schultz sits down with Dr. Aimee Duffy, a board-certified physician, BHRT (bioidentical hormone replacement therapy) specialist, and president of the North Carolina Integrative Medical Society, to ask a better question than "is this normal?" Namely, why were so many women pulled off hormone therapy in the first place, and was that decision ever actually justified?
The Study That Changed Everything (And Got Misread)
Most of the fear around hormone replacement therapy traces back to a single source: the Women's Health Initiative, a study from around 2002 that's still shaping how doctors talk to patients today.
Dr. Duffy breaks down what the study actually tested: Premarin and PremPro, synthetic, non-bioidentical hormones derived from pregnant mare's urine, given to a study population with an average age of 65. The study did find real risks, including increased breast cancer and stroke risk, and was cut short as a result.
The problem wasn't the finding. It was what happened next. Media coverage broadly condemned "hormone replacement" as a category, rather than the specific synthetic drugs that were actually tested. The result was a black box warning and decades of women being taken off or never offered hormone therapy that might have helped them, regardless of age, hormone type, or delivery method. (That warning was only partially lifted this past October, for vaginal estrogen.)
Bioidentical Isn't Just About the Molecule
According to Dr. Duffy, one of the most misunderstood parts of hormone therapy is what "bioidentical" actually means. It's not just about matching the molecular structure of the body's own hormones — it's about how that hormone is delivered.
She explains why she moves away from pellets and oral dosing in her own practice. Both can create what she calls hormone "floods and droughts" sharp spikes followed by steep drops rather than the steady, physiologic pattern the body is actually built to run on. Topical dosing, by contrast, more closely mimics the body's natural hormone rhythms, which is why it's her preferred approach for sustainable balance.
Why Guesswork Doesn't Belong in Hormone Therapy
The episode's clinical throughline is that treatment should be guided by testing, not assumption. Dr. Duffy walks through how she uses three different testing methods, each answering a different question:
- Saliva testing reflects what's actually available to the tissues, making it the most useful tool for dosing.
- Urine testing, collected across multiple samples, shows how hormones are being metabolized and flags safety concerns.
- Blood testing alone, once someone has started topical hormone therapy, is often the least accurate of the three a detail many practitioners and patients aren't aware of.
Without this kind of testing, hormone therapy becomes a guessing game and guessing is exactly what leads to the "floods and droughts" pattern Dr. Duffy is trying to move patients away from.
From Delivering Babies to Rewriting the Hormone Conversation
Dr. Duffy's path here wasn't a straight line. She fell in love with babies as a child, became a "mother's helper" at age 11, and decided to become an OB-GYN after witnessing a birth in high school. She ultimately went into family practice instead, working as a primary care and OB physician for women where she realized her medical training had left her without the tools to actually address women's hormone health. That gap is what led her into functional medicine and BHRT, and eventually into building a practice and training other practitioners around getting this right.
The Question Worth Asking
None of this means every woman needs hormone therapy, or that it's without nuance. But the episode makes the case that "normal aging" isn't a diagnosis, and fear rooted in a 20-year-old, misapplied study isn't a reason to skip testing altogether.
"The problem was never hormone therapy. It was one flawed study and a generation of women paid the price."
This episode is a reminder that being told your symptoms are "just part of aging" often isn't the end of the conversation, it's a sign the right questions haven't been asked yet.
Ready to stop guessing and start understanding your hormones? Learn More Here: https://www.drerikaonline.com/hormones
Listen here:
